+44 (0) 113 206 7503 Email us


Brachytherapy is a form of radiotherapy which is used to treat cancer. It is often known as internal radiotherapy and involves introducing a radioactive source into the body, either within or close to the tumour, enabling precise and highly targeted treatment delivery. It is particularly suitable for men with localised prostate cancer or in cases where there may be early spread of a cancer into nearby tissues.

There are two forms of brachytherapy for prostate cancer, both of which involve the injection of radioactive implants into the prostate gland. If high dose brachytherapy is required, the implants are usually temporary. In the case of low dose rate or permanent seed brachytherapy, the implants, called ‘seeds’, will remain inside the body, omitting continuous low-level radiation for around one year.

In both cases the radiation is highly targeted, minimising damage to surrounding tissue.

Nova Healthcare, working in partnership with Leeds Cancer Centre, is one of the leading brachytherapy centres in the UK in terms of both volume and expertise. We offer both high and low dose brachytherapy treatment, which may also be combined with external beam radiotherapy.

Consultants specialising in the treatment of brachytherapy

Dr David Bottomley

Consultant Clinical Oncologist

Dr Sree Rodda

Consultant Oncologist

Back to top

Nova Healthcare is part of Aspen Healthcare Group. Registered Office: Centurion House, 37 Jewry Street, London, EC3N 2ER. T: 020 7977 6080 E: info@aspen-healthcare.co.uk